Tower Research Capital (TRC)’s Genesis Healthcare, Inc. GEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-5,910
| Closed | -$2K | – | 6331 |
|
|
2021
Q1 | $2K | Sell |
5,910
-21,954
| -79% | -$15.6K | ﹤0.01% | 5131 |
|
|
2020
Q4 | $14K | Buy |
+27,864
| New | +$14.1K | ﹤0.01% | 4123 |
|
|
2020
Q3 | – | Sell |
-36,094
| Closed | -$25K | – | 5288 |
|
|
2020
Q2 | $25K | Buy |
36,094
+26,344
| +270% | +$21.2K | ﹤0.01% | 3577 |
|
|
2020
Q1 | $8K | Buy |
+9,750
| New | +$13.9K | ﹤0.01% | 2155 |
|
|
2019
Q4 | – | Sell |
-20,880
| Closed | -$23K | – | 4765 |
|
|
2019
Q3 | $23K | Buy |
+20,880
| New | +$24.1K | ﹤0.01% | 2392 |
|
|
2019
Q2 | – | Sell |
-8,554
| Closed | -$13K | – | 4611 |
|
|
2019
Q1 | $13K | Sell |
8,554
-5,874
| -41% | -$8.71K | ﹤0.01% | 2552 |
|
|
2018
Q4 | $17K | Sell |
14,428
-17,521
| -55% | -$26K | ﹤0.01% | 2082 |
|
|
2018
Q3 | $43K | Buy |
31,949
+29,597
| +1,258% | +$46.9K | ﹤0.01% | 1858 |
|
|
2018
Q2 | $5K | Buy |
+2,352
| New | +$4.54K | ﹤0.01% | 3097 |
|
|
2018
Q1 | – | Sell |
-12,346
| Closed | -$9K | – | 4108 |
|
|
2017
Q4 | $9K | Buy |
12,346
+8,778
| +246% | +$7.85K | ﹤0.01% | 2644 |
|
|
2017
Q3 | $4K | Buy |
3,568
+1,071
| +43% | +$1.35K | ﹤0.01% | 3436 |
|
|
2017
Q2 | $4K | Buy |
+2,497
| New | +$5.31K | ﹤0.01% | 2151 |
|
|
2017
Q1 | – | Sell |
-8,706
| Closed | -$37K | – | 4248 |
|
|
2016
Q4 | $37K | Buy |
8,706
+7,637
| +714% | +$25.2K | ﹤0.01% | 1645 |
|
|
2016
Q3 | $3K | Buy |
+1,069
| New | +$2.46K | ﹤0.01% | 2946 |
|
|
2016
Q2 | – | Sell |
-6,036
| Closed | -$14K | – | 5229 |
|
|
2016
Q1 | $14K | Sell |
6,036
-2,075
| -26% | -$4.69K | ﹤0.01% | 1656 |
|
|
2015
Q4 | $28K | Buy |
+8,111
| New | +$38.8K | ﹤0.01% | 966 |
|
|
2015
Q3 | – | Sell |
-13,697
| Closed | -$90K | – | 5078 |
|
|
2015
Q2 | $90K | Buy |
13,697
+4,896
| +56% | +$33K | 0.01% | 932 |
|
|
2015
Q1 | $63K | Buy |
+8,801
| New | +$66.4K | 0.01% | 1280 |
|
Tower Research Capital (TRC)'s GEN Position: Q2 2021 in Review
Tower Research Capital (TRC) sold out of Genesis Healthcare, Inc. (GEN) in Q2 2021, closing a stake of 5,910 shares — an estimated $2K sold.
Tower Research Capital (TRC) first reported a position in GEN in Q1 2015 and held it in 18 quarters. The position peaked at $90K in Q2 2015. 1 fund tracked by Wall St. Rank holds GEN as of Q2 2021.
- Tower Research Capital (TRC) reported no remaining Genesis Healthcare, Inc. position as of Q2 2021 after selling out during the quarter.
- Tower Research Capital (TRC) sold 5,910 Genesis Healthcare, Inc. shares in Q2 2021, an estimated $2K.
- Tower Research Capital (TRC) first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 18 quarters.
- Tower Research Capital (TRC)'s Genesis Healthcare, Inc. position peaked at $90K in Q2 2015.
- 1 fund tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q2 2021.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.